Displaying 13 - 24 of 24
Immune-Mediated and Cholestatic Diseases
1

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
1

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
1

Albireo: Challenges in the Management of Patients with Cholestatic Liver Diseases - Digital ILC 2020

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Displaying 13 - 24 of 24